The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 60-70 , January 2003

Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: Effect of immunosuppressive regimen

Read at the Eightieth Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, May 1-3, 2000.

Received 4 May 2000 ,Revised 22 August 2002 ,Accepted 9 September 2002.

  • Image Result

    Actuarial survival of the 3 groups. Actuarial survival at 300 days after transplantation was 14.3% in regimen A animals, 50% in regimen B animals, and 40% in regimen C animals.

    Actuarial survival of the 3 groups. Actuarial survival at 300 days after transplantation was 14.3% in regimen A animals, 50% in regimen B animals, and 40% in regimen C animals.

  • Image Result

    Change in ejection fraction. Although there were no important differences among the 3 groups, regimen A and B animals showed lower values compared with those of control animals (P = .0344 and .0187, r

    Change in ejection fraction. Although there were no important differences among the 3 groups, regimen A and B animals showed lower values compared with those of control animals (P = .0344 and .0187, respectively). *Existence of difference between periods (P = .0061 for regimen A animals, P < .0001 for regimen B animals, and P = .0167 for regimen C animals).

  • Image Result
    Change in body weight. All but one of the study animals increased in body weight naturally. The normal values for 94% of the animals lies between −2 and 2 (z value = [Observed data − Mean of normal gr

    Change in body weight. All but one of the study animals increased in body weight naturally. The normal values for 94% of the animals lies between −2 and 2 (z value = [Observed data − Mean of normal group]/SD).

  • Image Result
    A, CD2+CD4+ T cells decreased in all groups compared with control values (P < . 0001), and differences existed among the 3 groups (P = .0071 between regimens A and B and P = .0008 between regimens B a

    A, CD2+CD4+ T cells decreased in all groups compared with control values (P < . 0001), and differences existed among the 3 groups (P = .0071 between regimens A and B and P = .0008 between regimens B and C). *P = .2523 in regimen A, P = .0006 in regimen B, and P < .0001 in regimen C between both periods. B, CD25+CD2+ IL-2-activated T-cell profile. During rejection-free periods, all groups showed lower numbers compared with control values (P < .0001 in regimens A and C and P = .0002 in regimen B). Regimen C was the lowest among the 3 groups in rejection-free periods (P = .0088 between regimens A and C, P < .0001 between regimens B and C). *P = .0587 for regimen A, P = .0073 for regimen B, and P < .0001 for regimen C between both periods.

 Address for reprints: Steven R. Gundry, MD, Department of Surgery, Loma Linda University Medical School and Medical Center, 11175 Campus St, Suite 21121, Loma Linda, CA 92354 (E-mail: Steven.Gundry@tenethealth.com).

☆☆ 0022-5223/2003 $30.00+0

PII: S0022-5223(02)73336-9

doi: 10.1067/mtc.2003.89

The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 60-70 , January 2003